21.12.2018
- In a settlement with the US Justice Department (DoJ) Actelion Pharmaceuticals, a Johnson & Johnson subsidiary, has agreed to pay $360 million to settle civil claims it used a...
17.04.2018
- For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...
28.09.2017
- Jane Griffiths: Consolidation in the pharma industry is here to stay: as market competition increases, M&As are one of the fastest ways for companies to obtain critical mass...
28.09.2017
- Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your...
27.09.2017
- Pharmaceutical companies are experiencing numerous challenges such as increasing cost pressures, declining autonomy or protocol-driven care. The reaction has to go beyond...
13.06.2017
- The European Commission has approved plans by US healthcare group Johnson & Johnson to acquire Swiss biotech Actelion, thus completing all global regulatory approvals. J&J said it...
04.04.2017
- Based on interim results of its $280 per share tender offer for all publicly held shares of Swiss biopharmaceuticals company Actelion, US healthcare giant Johnson & Johnson has...
27.01.2017
- Johnson & Johnson (J&J) has won its battle to acquire Swiss biotechnology firm Actelion. The deal announced on Jan. 26 foresees the New Jersey, USA-based healthcare company...
